Passage Bio, Inc. PASG
NASDAQ · United States · Health Technology
$4.12-0.08 (-1.93%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -2.44 | -2.27 | -7.5% | +2.3%$4.40→$4.50 |
| Q1 2026 | 2026-05-12 | -2.36 | -2.15 | -9.8% | +25.5%$4.40→$5.52 |
| Q4 2025 | 2026-03-03 | -4.09 | -2.80 | -46.1% | -3.9%$8.78→$8.44 |
| Q3 2025 | 2025-11-10 | -2.44 | -2.64 | +7.6% | +22.5%$6.28→$7.70 |
| Q4 2024 | 2025-03-04 | -4.00 | -4.00 | 0.0% | — |
| Q4 2023 | 2024-03-04 | -6.00 | -8.00 | +25.0% | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.